REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/29/2025
Back to search
Official data from USPTO
PRESENTIA NIPD GENETICS HEREDITARY CANCER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
09/30/2025
Trademark type
Combined
Nice classes
1, 42, 44
Filing date
12/23/2019
Registration date
09/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/29/2020
Last transaction
09/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CY
Examiner
MANGUBAT,ALEXANDER GEORGE
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three lines of stylized wording. The first line is "NIPD GENETICS" in gray in stylized form. The second line is "PRESENTIA" in stylized form, where "PRE" is in yellow, and "SENTIA" is in gray. The third line is "HEREDITARY CANCER" in yellow.
Holders and representatives
Holders
MEDICOVER PUBLIC CO LTD
NIPD Genetics Public Company Limited
Representatives
Paulo A. de Almeida Patel & Almeida PC
Technical classification
Nice Classes
Class 1Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Kits and reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; kits and reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits and reagents for testing cancer diseases for medical and scientific research purposes
Class 42
Medical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering servicesscientific research in the field of genetic engineering; scientificlaboratoryclinicalmedicaltechnological research and analysis services in the fields of nucleic acid analysiscancer testinggenetics; scientific research for medical purposes in the field of cancerous diseases
Class 44
Medical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosisprevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA and DNA analysis for cancer diagnosis and prognosis
Publications
History of USPTO decisions and trademark events.
37 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/16/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/14/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/02/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/23/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/15/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
01/15/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/29/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/14/2020
PUBO
PUBLISHED FOR OPPOSITION
07/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/24/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/26/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/26/2020
RFNT
REFUSAL PROCESSED BY IB
04/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2020
RFRR
REFUSAL PROCESSED BY MPU
04/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/20/2020
CNRT
NON-FINAL ACTION WRITTEN
03/19/2020
DOCK
ASSIGNED TO EXAMINER
03/19/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/27/2020
Continuous trademark protection
Get notified about every new filing that threatens PRESENTIA NIPD GENETICS HEREDITARY CANCER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.